American Journal of Clinical Dermatology

Article	Citations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	311
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	144
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	120
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	106
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	90
Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE	89
Disease Duration in Patients Recruited to Psoriasis Phase III Trials: A Systematic Review	88
Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials	84
Performance of Staging Systems for Non-head and Neck Cutaneous Squamous Cell Carcinoma	80
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	79
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	77
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	76
The Burden of Pediatric Psoriasis: A Systematic Review	75
Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study	73
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks	69
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	68
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	68
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	65
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	64
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	61
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	57
Skin Cancer in Solid Organ Transplant Recipients: A Review	57
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	57
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	57
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	57

48-Week Real-World Outcomes of Lebrikizumab Treatment for Atopic Dermatitis: Systemic Therapy-Naive Versus -Experienced Patients	56
Considerations for Genital Psoriasis Care Across Age Groups: A Modified Delphi Consensus Initiative from the Genital Psoriasis Wellness Consortium	56
Systemic Treatments in Moderate-to-Severe Atopic Dermatitis in Pediatric Patients up to 12 Years of Age: Real-World Treatment Outcomes from the PEDISTAD Registry	55
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	54
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	52
Ethnic Differences of Palmoplantar Pustulosis: A Systematic Review	51
A Practice Approach to Acne Fulminans in Adolescents	50
Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!	49
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	47
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	46
Dissecting Cellulitis of the Scalp: Current Insights and Therapeutic Advances	46
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	44
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	43
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	40
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	40
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	39
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	38
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	37
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	36
Oral Lichen Planus: An Update on Diagnosis and Management	36
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	36
Exposome Risk Factors for Vitiligo: A Systematic Evidence Review	34
A Systematic Review of Factors Influencing Adult Adherence to Topical Medications in Atopic Dermatitis	34
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	32
Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States	30
The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?	30
Frontal Fibrosing Alopecia: An Update	30
Individualized Neoantigen-Directed Melanoma Therapy	30
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	29
The Burden of Acne Vulgaris on Health-Related Quality of Life and Psychosocial Well-Being Domains: A Systematic Review	29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	29
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	28
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	27
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	27
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	26
Circulating Tumor DNA as a Biomarker for Melanoma Prognosis and Therapy	26
Efficacy and Safety of Oral Janus Kinase Inhibitors in Adults and Adolescents with Alopecia Areata: A Systematic Review and Meta-Analysis of Randomised Controlled Trials	25
Advancing Precision Medicine in Inflammatory Skin Disease	25
Targeting Inflammation in Acne: Current Treatments and Future Prospects	25
What’s New in Photoprotection?	25
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	24
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	24
Acknowledgement to Referees	24
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	23
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	22
Exploring Suzetrigine's Role in Dermatologic Surgery: A Novel Nonopioid Analgesic for Postoperative Pain Management	21
Management of Acne in Pregnancy	20
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	20
Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review	20

Acknowledgement to Referees	20
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	20
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	20
Approach to the Atypical Wound	19
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	19
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	19
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	19
Real-World Treatment with Lebrikizumab or Tralokinumab for Atopic Dermatitis: A 60-Week Retrospective Comparative Study	18
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results	18
Defining Moderate Disease and Progression in Hidradenitis Suppurativa: An Expert Framework to Unlock the Window of Opportunity for Prompt Treatment	18
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	18
Is There a Place for Biologics in Acne?	17
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	17
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations	17
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	17
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	17
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	17
Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	16
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	16
High-Frequency Ultrasound in Hidradenitis Suppurativa: From Lesion Detection to Iconographic Lesion-Level Management	16
Safety of Hydroxychloroquine: What a Dermatologist Should Know	16
An Update on New and Existing Treatments for the Management of Melasma	16
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	16
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	15
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	15
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	15
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	15
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	15
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	15
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	15
Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study	14
Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients	14
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	14
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	14
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	14
Atopic Dermatitis Across Shades of Skin	14
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	14
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	14
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	14
Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study	14
Genomics of Primary and Metastatic Cutaneous Melanoma: A Systematic Review and Meta-Analysis	14
Mastering the Use of Systemic JAK Inhibitors for Atopic Dermatitis: A Dermatologist's Practical Guide	13
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	13
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	13
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	12
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	12
Alopecia in Children with Cancer: A Review from Pathophysiology to Management	12
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	12
Lichen Planus: What is New in Diagnosis and Treatment?	12
Correction to: Adherence to Hidradenitis Suppurativa Treatment	11
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	11
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	11
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis	11
Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies	11
Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks	11
Dapsone Use in Dermatology	11
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb Studies	11
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	10
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	10
Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast	10
Management of Erythrodermic Psoriasis with Systemic Therapies: A Systematic Review	10
What’s New in Therapy for Male Androgenetic Alopecia?	10
Understanding the Clinical Spectrum of the Cutaneous and Acute Hepatic Porphyrias	10
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	10
Alopecia Areata: Current Treatments and New Directions	9
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	9
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	9
Eyebrow and Eyelash Alopecia: A Clinical Review	9
Adherence to Hidradenitis Suppurativa Treatment	9
Deucravacitinib for the Treatment of Psoriatic Disease	9
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	9
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	9
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of Psoriasis	9
Psoriasis: Considerations for the Management of Women of Childbearing Potential	8
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	8
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	8
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	8
Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology	7
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	7
Understanding Enthesitis in Psoriatic Disease: Insights and Implications	7

Safety and Tolerability of Ruxolitinib Cream in Adolescents with Mild-to-Moderate Atopic Dermatitis: Results From a 1-Year, Phase III, Open-Label Study	7
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	7
Nicotinamide for Skin Cancer Chemoprevention: The Jury Was Out and Still is	7
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	7
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase	7
Acute and Chronic Cutaneous Graft-versus-Host Disease: Diagnosis, Treatment, and Emerging Directions	7
Perioperative Systemic Therapy for High-Risk Cutaneous Squamous Cell Carcinoma	7
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	7
Atopic Dermatitis: New Targets and Emerging Systemic Therapies	7
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS)	7
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	7
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	7
Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	7
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	6
Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis	6
Long-Term Real-World Evaluation of Abrocitinib in Moderate-to-Severe Atopic Dermatitis Across a Diverse Patient Population in a Multi-site Hospital System	6
Menopause and Common Dermatoses: A Systematic Review	6
A Systematic Review of the Clinical Impact of GLP-1 Receptor Agonists in Hidradenitis Suppurativa	6
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries	6
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024	6
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	6
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	6
Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies	6
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial	6
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?	6
Hidradenitis Suppurativa: New Targets and Emerging Treatments	6
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	6
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	6
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study	6
Effectiveness of Systemic Treatments for Atopic Dermatitis in the Head-and-Neck-Area: A Systematic Review and Meta-analysis	6
Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials	6